```
prompt_version: stage1-v16.1-20260414
model_info: claude-sonnet-4-6

target_title:   Palladium-Catalyzed Reductive Heck Hydroarylation of Unactivated Alkenes Using Hydrosilane at Room Temperature
target_authors: Takahiro Shirai, Yusuke Migitera, Ryo Nakajima, Takuya Kumamoto
target_start:   page 2787: [REDACTED: paper boundary quote; see Tier 9]
target_end:     end of document
```

## Step 0: Boundary recheck

All quotes from Turns 1–3 have been verified against the target paper (pp. 2787–2793, single paper, no adjacent paper in the PDF). No boundary violations detected. The paper uses page numbers 2787–2793 throughout, and all quoted passages appear within those pages. No quotes reference metals, ligands, or reactions absent from the target paper.

**Erratum note:** S0-7 reports "errors in Table 1" corrected in the Feb 6, 2024 repost. The PDF used here was downloaded in March 2026 and is presumed to be the corrected version. No passages are flagged with [erratum — corrected version unclear] as the erratum does not specify what was corrected; agents are instructed to treat the current Table 1 content as authoritative.

---

## Step 1: Cross-field temperature for overlapping questions

| Base item | V1 severity | V2 severity | V3 severity | Convergence | Temperature_gap |
|---|---|---|---|---|---|
| V1-Q10 (internal > terminal alkene) | high (3) | critical (4) [V2-OV1] | — | 2/3 | low (step=1) |
| V1-Q11 (Thorpe-Ingold failure) | high (3) | high (3) [V2-OV2] | — | 2/3 | none |
| V1-Q7 (regioselectivity ratios absent) | high (3) | high (3) [V2-OV3] | — | 2/3 | none |
| V1-Q1 (mass balance absent) | high (3) | — | high (3) [V3-OV1] | 2/3 | none |
| V1-Q15 (no replication) | medium (2) | — | high (3) [V3-OV2] | 2/3 | low (step=1) |
| V2-Q1 (deuterium shortfall) | — | high (3) | medium (2) [V3-OV3] | 2/3 | low (step=1) |

high_convergence_high_gap: none (all high-convergence items have temperature_gap = none or low)

---

## Step 2: Same-root groups

**SRG-1: "Quantitative performance data absent from substrate scope"**
Members: V1-Q1, V1-Q9, V1-Q13, V1-Q15, V3-Q2, V3-Q3, V3-Q4, V3-Q8
Shared root: The substrate scope table reports only isolated yields for single runs, without mass balance, byproduct tracking, replication, or comparison data needed to evaluate the paper's performance claims quantitatively.

**SRG-2: [REDACTED: substantial verbatim quotation; see Tier 9]**
Members: V1-Q10, V1-Q11, V2-Q4, V2-Q5, V2-Q2, V2-Q10
Shared root: Multiple selectivity observations (internal > terminal, Thorpe-Ingold failure, regioselectivity, addition-rate-controlled pathway competition) are unexplained or mechanistically unverified; all derive from the same absence of kinetic/mechanistic data.

**SRG-3: "Synthetic utility of AQ-group-containing products unaddressed"**
Members: V1-Q5, V1-Q14
Shared root: All products contain the AQ bidentate directing amide; the paper does not address removal or downstream utility, despite invoking pharmaceutical relevance.

---

## Step 3: Classification

[A] items

[A]
A-1 | P2791:Lcol* | [REDACTED: substantial verbatim quotation; see Tier 9] | deferred | mixed_detail: n/a | T1 | linked_to: B-2, B-3, U-1, U-2, U-3 | cross_field_temperature: V2-Q2=high, V2-Q3=critical (convergence 1/3 from V2 only for each; these questions are subsumed into A-1 as the explicit mechanistic deferral)

A-2 | P2787:Rcol* | [REDACTED: substantial verbatim quotation; see Tier 9] | suppressed | mixed_detail: n/a | T2 [paper-grounded inference] | linked_to: B-6, C-3, C-4 | note: Suppressed classification applied: (1) textual awareness of tension — paper invokes "protecting group-free total synthesis" (citing Baran, ref 11) and FDA pharmaceutical relevance while using AQ-protected substrates throughout; (2) textual move away — paper focuses on yield/FG-tolerance without discussing AQ removal; (3) paper does not return to address it.

---

[B] items

[B]
B-1 | P2788:Rcol* | [REDACTED: substantial verbatim quotation; see Tier 9] | reporting_omission | Rhetorical_function: Introduction to substrate scope section presenting isolated product yields without accounting for competing reaction pathways. | note: Mass balance absent — byproduct formation (1b olefin migration, 1c reduction product) tracked in optimization but untracked across scope table; V1-Q1=high, V3-OV1=high. [metric incompleteness flag] [same_root_group: SRG-1] | cross_field_temperature: V1=high, V3=high; convergence=2/3; temperature_gap=none

B-2 | P2788:Rcol* | [REDACTED: substantial verbatim quotation; see Tier 9] | mixed | Rhetorical_function: Scope observation presented as a positive scope demonstration acknowledging but not explaining a mechanistic anomaly. | note: Paper explicitly acknowledges the anomaly (methodological_limitation) but frames it as a successful scope result without explanation (intentional_narrowing: positive framing); V1-Q10=high, V2-OV1=critical. [negative result as evidence — the counterintuitive yield pattern is presented as confirmation of scope breadth without mechanistic analysis] | cross_field_temperature: V1=high, V2=critical; convergence=2/3; temperature_gap=low

B-3 | P2788:Rcol* | [REDACTED: substantial verbatim quotation; see Tier 9] | mixed | Rhetorical_function: Scope observation that states a falsified prediction without offering an alternative explanation. | note: Paper states the expectation and the contradicting result (methodological_limitation) while framing the results as positive scope examples (intentional_narrowing); V1-Q11=high, V2-OV2=high. | cross_field_temperature: V1=high, V2=high; convergence=2/3; temperature_gap=none

B-4 | not recoverable | [absence of any replication statement throughout the substrate scope and optimization sections] | reporting_omission | Rhetorical_function: not stated in paper | note: All NMR and isolated yields are single-point measurements without replication or uncertainty estimates; V1-Q15=medium, V3-OV2=high. [same_root_group: SRG-1] | cross_field_temperature: V1=medium, V3=high; convergence=2/3; temperature_gap=low

B-5 | P2789:Lcol* | [REDACTED: substantial verbatim quotation; see Tier 9] | reporting_omission | Rhetorical_function: Comparative performance claim positioning this work as superior to prior art in yield as well as conditions. | note: No side-by-side comparison table; specific prior yields and conditions not reproduced; V1-Q13=high, V3-Q8=high. [metric incompleteness flag] [same_root_group: SRG-1]

B-6 | P2787:Rcol* | [REDACTED: substantial verbatim quotation; see Tier 9] | intentional_narrowing | Rhetorical_function: Positive framing of the AQ directing group as a selectivity-enabling feature without acknowledging the substrate class restriction it imposes. | note: All scope substrates bear the AQ bidentate directing amide; substrates without AQ excluded without discussion; V1-Q5=high, V1-Q14=high. [substrate selection bias flag] [same_root_group: SRG-3]

B-7 | P2789:Rcol* | [REDACTED: substantial verbatim quotation; see Tier 9] | mixed | Rhetorical_function: Mechanistic evidence from isotope labeling presented as supporting the proposed dual-cycle without quantitative kinetic analysis. | note: 0.2 D shortfall attributed to protodepalladation by amide NH but the ratio is not quantified; NMR acquisition parameters for deuterium quantification not stated (V3-Q5=medium, reporting_omission); no independent confirmation of amide-NH delivery (V2-Q7=medium, methodological_limitation). | cross_field_temperature: V2=high, V3=medium; convergence=2/3; temperature_gap=low

---

[C] items

[C]
C-1 | P2787:Rcol* (introduction) | Refs 8–10 (Ghosh ChemistrySelect 2019; Oxtoby et al. Trends Chem. 2019; Xie et al. Chin. J. Chem. 2021) | Textual_function: Background citations establishing reductive Heck hydroarylation as an established synthetic class. | Reason_severed: No specific findings from these review articles are compared or discussed; cited en bloc as field context. | affects_claims: yes — these reviews cover the breadth of prior methods; non-engagement prevents evaluation of whether the three stated drawbacks (I, II, III) apply universally or only to specific protocols. | symmetric_pattern: yes

C-2 | P2787–2788:* | Refs 15–20 (Hu 2018; Wang/Wu 2018; Zheng/Loh/Wu 2020; Guo/Loh/Wu 2020; Li/Gong/Song 2020) | Textual_function: Prior art with identified drawbacks (I: high temperature, II: amino group incompatibility, III: reducible substituent incompatibility) that motivated this work. | Reason_severed: Despite the claim [REDACTED: substantial verbatim quotation; see Tier 9] (ref B-5), no prior yields or conditions are reproduced for direct comparison; drawbacks I–III are asserted without citing specific examples from these references. | affects_claims: yes — the core novelty argument rests on overcoming drawbacks from these references, but the extent and generality of those drawbacks is stated, not demonstrated. | symmetric_pattern: partial (refs 16, 18, 19 represent the Wu/Loh group's closely related work; ref 15 = Hu et al., different substrate class; ref 20 = Gong/Song, δ-selective variant — internal differentiation warranted)

C-3 | P2787:Rcol* | Ref 11 (Baran, Maimone, Richter, Nature 2007) | Textual_function: Motivational citation for "protecting group-free total synthesis" context. | Reason_severed: Cited as aspirational synthetic goal; no connection to this work's experimental design or substrate selection. | affects_claims: no — purely motivational context. | symmetric_pattern: no

C-4 | P2787:Rcol* | Refs 29–31 (WHO Essential Medicines 2021; Seferovic et al. Lancet 2017; Karnik et al. JAPI 1998) | Textual_function: Establish pharmaceutical relevance of fatty acid alkylarene skeletons found in FDA-approved drugs. | Reason_severed: No structural comparison between scope substrates and actual pharmaceutical targets; cited for motivation only. | affects_claims: no — background motivation only. | symmetric_pattern: yes

C-5 | P2787:Rcol* | Ref 24 (Zaitsev, Shabashov, Daugulis JACS 2005) | Textual_function: Attribution of the AQ directing group concept. | Reason_severed: Original AQ C-H activation paper not engaged beyond attribution; AQ mechanism and its generality not discussed. | affects_claims: no | symmetric_pattern: no

C-6 | P2787:Rcol* | Refs 25–28 (Gurak/Engle JACS 2016; Yang/Gurak/Engle JACS 2016; Wang et al. JACS 2018; Matsuura et al. Chem. Sci. 2018) | Textual_function: Precedent establishing AQ-directed regiocontrolled alkene functionalization. | Reason_severed: Cited as establishing mechanistic precedent for AQ directing group regioselectivity; no specific yield, selectivity ratio, or scope comparison made. | affects_claims: medium — these papers established the directing-group mechanistic precedent this work applies; non-engagement prevents evaluation of whether regioselectivity in this hydroarylation is quantitatively comparable to or distinct from those established systems. | symmetric_pattern: yes

---

[U] items

[U]
U-1 | P2788:Lcol* | [REDACTED: substantial verbatim quotation; see Tier 9] | Under optimized conditions, 11% of reduction byproduct 1c still forms for model substrate 3aa. For substrates requiring increased PMHS loading (3.1 or 4.1 equiv), formation of 1c and/or 1b under those conditions is not reported. Does greater PMHS loading increase Si–PdII–H formation and thereby increase byproduct 1c? | V1, V1-Q9 | high | self-contradictory absence — the paper's proposed dual-cycle mechanism predicts that Si–PdII–H formation, and thus byproduct 1c, should vary with PMHS loading and addition rate across substrates; this is a directly predicted variable that is neither reported nor acknowledged as untested for the substrate scope.

U-2 | P2789:Rcol* | [REDACTED: substantial verbatim quotation; see Tier 9] | In the Si-D experiment, 0.2 D is unaccounted at the γ-position; in the deuterated amide experiment (Figure 3b), 0.2 D appears at the δ-position. Could a single mechanistic scenario explain both observations without requiring two independent competing cycles? Specifically, does the 0.2 D at δ in Figure 3b arise from the same pathway that accounts for the 0.2 D deficit in Figure 3a? | V2, V2-Q1 | high | self-contradictory absence — the paper's proposed dual-cycle mechanism predicts a specific isotopic labeling pattern from each cycle; the two labeling experiments are used as corroborating evidence, but their quantitative consistency with two independent competing cycles rather than one cycle with multiple H-delivery routes is neither verified nor acknowledged as ambiguous.

U-3 | P2790:Lcol* | [REDACTED: substantial verbatim quotation; see Tier 9] | The proposed catalytic cycle assigns Pd(0) as the active oxidative addition species, but no experiment distinguishes homogeneous Pd(0), Pd(0) nanoparticles (heterogeneous), or a Pd(II)-hydride generated by σ-bond metathesis of Pd(II) with PMHS. A Hg-drop test or comparison with an isolated Pd(0) complex was not performed. | V2, V2-Q3 | critical | A/B/C does not apply: the paper presents the Pd(0) assignment as part of a proposed (not proven) mechanism, so it is not a reporting_omission of a standard datum (B) nor a deferred question (A — the mechanism as a whole is deferred by A-1, but the Pd species identity is a foundational assumption of the proposed cycle, not merely a detail); it is a structural gap in the evidentiary basis of the cycle itself.

U-4 | P2790:Lcol* | "Si−PdII−H species generated from the Pd0 catalyst and Si−H" | The paper assumes a closed-shell ionic mechanism throughout. No radical clock experiment, EPR, or crossover study is reported to exclude a silyl radical chain mechanism for the side pathway (formation of 1c). [external inference — ref 43 in the paper (Mirza-Aghayan et al.) concerns Pd/Et3SiH reduction of olefins and is cited in the context of Si–PdII–H formation; silyl radical pathways in Pd/hydrosilane systems are not addressed.] | V2, V2-Q9 | high | A/B/C does not apply: the ionic mechanism is assumed, not deferred or limited — the paper does not acknowledge the radical pathway alternative, making this neither a prospective gap (A) nor an acknowledged limitation (B); it is an unrecognized alternative mechanistic pathway.

---

[META]
  linked_items:
    - A-1 ↔ B-2 (mechanistic explanation for anomalous scope results deferred by A-1)
    - A-1 ↔ B-3 (mechanistic explanation for Thorpe-Ingold failure deferred by A-1)
    - A-1 ↔ U-1 (deferred mechanism connects to unreported byproduct variation across scope)
    - A-1 ↔ U-2 (deferred mechanism connects to incomplete isotope pattern analysis)
    - A-1 ↔ U-3 (deferred mechanism rests on unverified Pd(0) active species assignment)
    - A-1 ↔ U-4 (deferred mechanism does not address radical pathway alternative)
    - A-2 ↔ B-6 (suppressed AQ utility question connects to intentional narrowing of substrate scope)
    - A-2 ↔ C-3 (protecting-group-free synthesis motivation cites Baran but AQ removal not addressed)
    - A-2 ↔ C-4 (pharmaceutical relevance claimed but AQ group prevents direct use of products)
    - B-1 ↔ U-1 (mass balance omission in scope connects to self-contradictory byproduct absence)
    - B-5 ↔ C-2 (comparison claim without data connects to uncontinued prior-art citations)

  same_root_groups:
    - SRG-1: [B-1, B-4, B-5, U-1] — [REDACTED: substantial verbatim quotation; see Tier 9]
    - SRG-2: [B-2, B-3, A-1, U-2, U-3, U-4] — [REDACTED: substantial verbatim quotation; see Tier 9]
    - SRG-3: [A-2, B-6, C-3, C-4] — [REDACTED: substantial verbatim quotation; see Tier 9]

  symmetric_citations: [C-1 (refs 8–10), C-4 (refs 29–31), C-6 (refs 25–28)]

  unreported_data:
    - Byproduct formation data (1b, 1c) for all substrate scope entries in Figure 2
    - NMR/crude yields for substrate scope entries (only isolated yields reported)
    - Regioisomer ratios for all products in Figure 2a and 2b
    - Pd loading optimization data
    - Aryl bromide compatibility screening
    - Slow-addition rate sensitivity data

  series_signal: no

[TEMPERATURE_SUMMARY]
  high_convergence_high_gap: none
    (Note: All high-convergence items have temperature_gap = none or low. Fallback rule applies in Stage 2 D-4.)

  high_convergence_low_gap: [B-1 (V1=high, V3=high; gap=none; convergence=2/3), B-2 (V1=high, V2=critical; gap=low; convergence=2/3), B-3 (V1=high, V2=high; gap=none; convergence=2/3), B-4 (V1=medium, V3=high; gap=low; convergence=2/3), B-7 (V2=high, V3=medium; gap=low; convergence=2/3)]

  low_convergence_high_gap: [U-3 (V2-Q3=critical, convergence=1/3 — only V2 flagged; active Pd species identity as critical gap)]

[GAP]
GAP-1 | type: 1 | priority: high | description: Prior yield data from Wu/Loh (refs 16, 18, 19) and Gong/Song (ref 20) needed to evaluate comparative performance claim in B-5 | candidate_paper: Wang et al. JACS 2018 (ref 16); Zheng et al. Org. Lett. 2020 (ref 18); Li et al. Org. Chem. Front. 2020 (ref 20) | T1 | status: pending

GAP-2 | type: 3 | priority: high | description: Kinetic investigation of rate-determining step and radical vs. ionic pathway discrimination needed to answer A-1 and U-4 | candidate_paper: not specified (future experimental work) | T2 [paper-grounded inference] | status: pending

GAP-3 | type: 1 | priority: medium | description: AQ-directed regioselectivity precedent (refs 25–28) would allow evaluation of whether regioselectivity in this system is quantitatively established | candidate_paper: Gurak/Engle JACS 2016 (ref 25); Yang/Gurak/Engle JACS 2016 (ref 26) | T2 [paper-grounded inference] | status: pending

GAP-4 | type: 3 | priority: medium | description: Mechanistic studies distinguishing Pd(0) homogeneous vs. heterogeneous active species (U-3) would address the foundational assumption of the proposed catalytic cycle | candidate_paper: not specified | T2 [paper-grounded inference] | status: pending

inference_time_sec: not available — inject externally

---

> **Tier 8 redaction notice**: This file is a redacted copy of the corresponding Tier 3 / Tier 9 output. Verbatim source-paper quotations have been replaced by `[REDACTED: see source paper §<loc>; full text retained in Tier 9 reviewer-only deposit]` markers, preserving location references and our own analytical content. Bibliographic fields (title, authors, journal, year, DOI), analytical labels (`evidence_chain:` with B-/U-/A-/C- internal IDs), short technical terms, and our own analytical text are not redacted. The redaction was applied by `scripts/redact_for_tier8.py` and, for this version, by `scripts/build_paperA_R1_public.py` with `scripts/redact_source_ngram_runs.py` (scripts of the project repository; they are not deposited).
